Current status of immunosuppressive agents for solid organ transplantation in children.
Pediatr Transplant
; 16(2): 106-22, 2012 Mar.
Article
em En
| MEDLINE
| ID: mdl-22360399
ABSTRACT
Immunosuppression after organ transplantation is complex and ever evolving. Over the past two decades, newer immunosuppressive agents have been introduced with an aim to provide better patient and graft survival. Improved therapeutic strategies have been developed offering the option to use combinations of drugs with non-overlapping toxicities. There are, however, only a few clinical studies with robust data to rationalize the use of these agents in children. This review will discuss the newer immunosuppressive agents used for solid organ transplant, their current status in post-transplant management and prevention of allograft rejection.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Transplante de Órgãos
/
Rejeição de Enxerto
/
Imunossupressores
Limite:
Child
/
Humans
Idioma:
En
Revista:
Pediatr Transplant
Assunto da revista:
PEDIATRIA
/
TRANSPLANTE
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
Reino Unido